Business Today, April 28, 2022
Last week, the Centers for Disease Control and Prevention (CDC) confirmed that at least four people in Michigan, US, were infected with a version of the coronavirus observed mostly in minks during the first year of the pandemic.
Weill Cornell Medicine Center for Global Health, April 28, 2022
PDF: Dr. Gauri Dhumal was interviewed for the Weill Cornell Medicine Center for Global Health's Female Global Scholars newsletter. It is part of the Women In Global Health Research Initiative.
BUSINESS STANDARD, April 21, 2022
Vaccine inequity remains an issue both within India, where less than 2 per cent of the population has received a Covid booster, and the globe with 56 countries unable to inoculate even 10 percent of their people, says Johns Hopkins scientist Amita Gupta.
This story was also run by:
Business Today,
Fox Business News,
Mint,
News18,
The Hindu Business Line,
The New Indian Express,
Zee News
THE PRINT, April 19, 2022
Though Covid cases are rising in Delhi and its satellite towns, the focus should be on hospital admissions that have remained the same or changed just marginally, say several scientists, underscoring that the uptick is not an indication of a fourth wave in the country at this point.
India.com, April 19, 2022
Amid Rising Cases, Health Experts Issue Word of Caution. Experts are of the opinion the rise in COVID cases in Delhi and some other states may be a result of relaxed restrictions, pandemic fatigue, and higher transmissibility of the virus.
Think Global Health, April 12, 2022
Poverty: Protecting community health workers will help the vast nation ride out future waves
Financial Express, April 11, 2022
Interview with Raj Gupta. "The aim is to promote multidisciplinary solutions to the world’s most vexing problems by expanding university partnerships in India and creating greater opportunities for India-related work."
THE BUSINESS STANDARD, April 08, 2022
Covid has exposed a need for efficient healthcare delivery system, said NITI Aayog CEO, adding that technology and research solution that provide data-based information quickly is the need of the hour.
This story was also run by: Business Insider, Drug Today, Insight Online, Newsgram, The Newsmen
ALLIED24X7NEWS, April 08, 2022
Youtube: Welcoming Address by Johns Hopkins University Provost Sunil Kumar.
THE ECONOMIC TIMES HEALTHWORLD, April 05, 2022
One of the roles of the Gupta-Klinsky India Institute is to bring together Johns Hopkins’ faculty, staff, students, and alumni to engage with the private sector in India to learn and work on high quality, solution-based initiatives that can be employed globally for sustainable social impact.
The Print, April 07, 2022
“We were worried about BA.2 but it did not cause more serious disease than BA.1. XE does not cause more serious disease than BA.1 or BA.2 (sub-variants of Omicron),” she said on the sidelines of a panel discussion organised by Gupta-Klinsky India Institute of the Johns Hopkins University here.
She added that in a vaccinated population, XE variant is not something to be bothered about. The World Health Organization (WHO) has issued warning against XE, a new variant of Omicron first detected in the UK.
This story was also run by: Bluzz, Busines Standard, CNBC TV 18, Deccan Herald, Eantube, Economic Times, First Post, Flipboard, Fresh Google News, GWN, Henry's club, Hindu Business Line, Hindustan Times, IG News, Indiaatoz, Info4now, Irshi Videos, Knowledia, MyAsianMarket Place, New Indian Express, News18, News7Trends, One India, Opera News, Pehal News, Search News, Tamil Bloggers.xyz, The News Minute, The Prime Hour, The Wire, Times Now News, Urall news
THE TIMES OF INDIA, April 06, 2022
Safe Zindagi, part of Program Accelerate and funded by USAID and Johns Hopkins University, has been working with the National AIDS Control Organization (Naco) since 2019 to advance progress towards the UNAIDS 95-95-95 goals to achieve epidemic control in India.
The Hindustan Times, April 04, 2022
The private sector in India has to lead SIRD with massive investment and shoulder the onus of funding and driving the segment, either through corporate investments or philanthropic grants. Op-ed by Raj Gupta
IndianWeb2, April 04, 2022
Keynote speaker, Dr. Saurabh Garg, CEO, UIDAI, and panelists including Suchitra Ella, Co-Founder & Joint MD, Bharat Biotech, Neera Nundy, Managing Partner & Founder, Dasra, Dr. Subhasis Chaudhuri, Director, IIT Bombay, Shekar Sivasubramanian, CEO, Wadhwani AI, and Viresh Prashar, Founder & CEO, Fruitfal, highlighted the role of the private sector in creating opportunities and lowering barriers to interdisciplinary knowledge sharing and shaping emerging technologies of the future.
This story was also run by:
Biospectrum India, Easy Shiksha, ET Healthworld, Express Computer, Global News On Network, Global Prime News, Healthcare Radius, Mumbai News Networks, News Jani, Pharmabiz, The Free Press Journal, UP Jobs News
The Indian Express, March 28, 2022
The study will generate evidence to inform about the feasibility and scalability of designing a comprehensive care program for TB /HIV patients with unhealthy alcohol use.
The NIH has funded a hybrid trial for alcohol reduction among people with TB and HIV in India (HATHI) that is set to begin in April in Pune. Johns Hopkins University in collaboration with Pune’s B J Government Medical College and Dr. D.Y. Patil Medical College, Hospital, and Research Center have developed a behavioral intervention to reduce alcohol use among TB/HIV patients.
The study aims at delivering the sessions to the patients with TB and/or HIV at BJGMC and Dr. DY Patil Medical College sites and assess the effectiveness of the intervention in reducing unhealthy alcohol use as well as improving the TB and HIV treatment outcomes,” Dr Nishi Suryavanshi, Deputy Director and Coordinator BJGMC-JHU Clinical Research Site and lead investigator said.
The Times of India, March 25, 2022
The anti-tuberculosis (TB) treatment in children is set to become shorter, more cost-effective and compliance-friendly, with the World Health Organization (WHO) strongly recommending change in the pediatric TB treatment duration from six months to four months in its latest guidelines. The new recommendation is based on the key findings of the Indian and African researchers who studied a total of 1,204 children for three years as a part of the multi-centric clinical research and established that a four-month treatment regimen was good enough to treat drug-susceptible and non-severe TB in children.
Mint, March 21, 2022
All countries must go beyond leveraging covid vaccination drives to counter its catastrophic effects.
The Leslie Marshall Show, March 08, 2022
During the second half of the show, Leslie is joined by Dr. Bob Bollinger. He is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University School of Medicine, and he holds joint appointments in International Health at the Johns Hopkins Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing. The two analyze new information on COVID-19 booster shots, and the latest news on the pandemic.
inHealth Precision Medicine Society at Johns Hopkins, February 03, 2022
At the Johns Hopkins University School of Medicine and Bloomberg School of Public Health, a team of researchers led by Professors Scott Zeger and Matthew Robinson have put precision medicine to work against COVID-19 through their development of the Severe COVID-19 Adaptive Risk Predictor (SCARP).
Johns Hopkins Medicine, February 03, 2022
Amita Gupta, M.D., M.H.S., an expert in the global treatment, prevention and control of diseases such as acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB), has been named as the seventh director of Johns Hopkins Medicine’s Division of Infectious Diseases. She takes over leadership of one of institution’s largest divisions — with more than 150 faculty members, clinical fellows and postdoctoral trainees — from David Thomas, M.D., M.P.H., who retired after 15 years as director.
THE TIMES OF INDIA, December 26, 2021
Days after the World Health Organization (WHO) recommended against the use of plasma therapy for Covid-19, a multi-centre clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health has reiterated the treatment is beneficial indeed.
CDC, December 07, 2021
These two new networks, paired with additional short-term research projects, will span more than 50 countries worldwide and build programs that focus on preventing infections in health care through proven infection control; build laboratory capacity to detect antimicrobial-resistant organisms in healthcare, the community, and environment; and develop new and innovative ways to more rapidly detect and respond to threats like AR and COVID-19.
USAID, November 30, 2021
The U.S. government, through the U.S. Agency for International Development (USAID) and the President’s Emergency Plan For AIDS Relief (PEPFAR), in partnership with Johns Hopkins University, organized the premier of the documentary ‘Mitr Clinic – Pride and Beyond’, which features India’s first comprehensive health clinic for the transgender community in Hyderabad. The documentary film showcases how USAID, the Government of India, civil society groups, and community leaders are working together to address the challenges faced by lesbian, gay, bisexual, transgender, queer, and intersex (LGBTQI+) persons in the country.
The Hindu, November 29, 2021
Op Ed by Brian Wahl and Gautam Menon (Subscription required)
Business Standard, November 25, 2021
Enormous amounts of data have been generated and analysed during the Covid-19 pandemic around the world. India has been there, too, and how. Amita Gupta, MD, is interviewed.
Contagion Live, November 12, 2021
India is the world’s leading consumer of antibiotics, and Amita Gupta, MD, is researching how the country can best mitigate the spread of antimicrobial resistance.
The Hindu, November 08, 2021
by Brian Wahl, Madhu Gupta, Neeraj Ghaywan
Med Page, October 22, 2021
by Ravi Mittal, MBBS, Surbhi Jain, MD, Christopher G. Myers, PhD, Tinglong Dai, PhD, and Amit Jain, MD
Public Health on Call , September 30, 2021
Drs. Vidya Mave and Brian Wahl discuss the current COVID situation in India with host Dr. Josh Sharfstein.
Barkha Dutt Live (India), September 04, 2021
Dr. Brian Wahl is a panelist in this discussion.
The Hindu (Subscription required), September 02, 2021
A model by Dr. Brian Wahl and colleagues shows that a rise in cases in children could occur, but in-person schooling can proceed with caution.
Financial Times (India), July 20, 2021
Dr. Brian Wahl is quoted in this report
Barkha Dutt Live. Mojo Sotyr (India), July 17, 2021
Dr. Brian Wahl participated in this panel discussion
Financial Times, July 05, 2021
Dr. Brian Wahl: “To prevent a third wave, we need to reduce opportunities for transmission,” Wahl said. “If we just get back to business as normal, a third wave is probably inevitable.”
Johns Hopkins Medicine Dome, July 01, 2021
As India recovers from its second wave of COVID-19, Johns Hopkins faculty members, staff members and medical students are helping to secure critical supplies, translate information and solicit donations.
India Today, June 28, 2021
Dr. Brian Wahl is interviewed about COVID-19 vaccine hesitancy, and encourages viewers to get the vaccine as soon as it is available to protect themselves and others.
NPR, June 21, 2021
Dr. Bhakti Hansoti is interviewed about the COVID-19 Delta variant, vaccines, and more.
PLOS Blogs, June 21, 2021
Dr. Anita Shet and colleagues outline the value of online courses in global health settings and the impact the pandemic had on advancing the field.
The Wire, June 15, 2021
Brian Wahl of the Johns Hopkins Bloomberg School of Public Health says people must meticulously wear masks and maintain social distancing at all times.
Gruntstuff, June 14, 2021
Dr. Amita Gupta: “What occurs in India issues to your entire world,” mentioned Dr. Amita Gupta, chair of the Johns Hopkins India Institute in a Fb dialog Thursday. “We care from a humanitarian perspective, a public well being perspective and a well being safety perspective.”
Salon, June 12, 2021
Dr. Robert Bollinger: “All RNA viruses mutate over time, some more than others … For instance, flu viruses are particularly prone to mutation, which is why new strains circulate every year.”
SELF, June 11, 2021
Dr. Amita Gupta: “If raw materials are the issue, it’s a global issue, not specific to India. The amount of vaccine that can be made for everybody needs to be carefully thought through.”
USA Today, June 11, 2021
Dr. Bhakti Hansoti: “We need masking in public areas, limited gathering sizes and increased scrutiny in schools and public spaces … If not, after the Delta variant, another variant will just come and surge again.”
TIME, June 09, 2021
Dr. Amita Gupta was a survey participant in this TIME project to identify strategic priorities for pandemic prevention.
The Hindu, June 08, 2021
Dr. Brian Wahl is featured. (Subscription required)
editorji, May 31, 2021
Dr. Amita Gupta was a panelist on the live Twitter show with Vikram Chandra
News Medical, May 31, 2021
Brian Wahl, an epidemiologist at the Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, US, tells SciDev.Net: “In the last year, we have seen [multiple] ways in which COVID-19 has disproportionately affected vulnerable populations, including essential workers and those with limited access to medical services.”We will never know the exact impact of the pandemic on human health. However, the estimates released by WHO of excess deaths for 2020 are helpful for beginning to wrap our heads around this difficult issue,” he comments.
India Today, May 26, 2021
Dr. Brain Wahl joins a panel discussion discussing a possibility of a 3rd COVID wave.
Johns Hopkins Nursing Magazine, May 24, 2021
Dr. Nancy Reynolds discusses the current situation on the podcast
Indian Express, May 21, 2021
Dr. Vidya Mave: Many data scientists, representing PMC, MCCIA, PKC, IT companies, etc were involved in the analysis of available data in May-June of 2020 and used computational modeling to help predict the number of tests and cases that would occur in subsequent months. This, in turn, formed the basis for the Covid-19 response, and Pune city was ready for the September peak of the first wave.
USA Today, May 21, 2021
“The (Gateway Pundit) article shows no data, much less any that would demonstrate an effect of any kind of prophylaxis on reducing COVID incidence in India,” Dr. David Peters, chair of the international health department at Johns Hopkins University, said in an email to USA TODAY.
Johns Hopkins Bloomberg School of Public Health, May 20, 2021
Drs. Anita Shet and David Peters provided a media briefing for journalists.
Boston Herald, May 20, 2021
“This is a problem not just for those in India, but it’s a problem for everyone,” said Dr. David Peters of the Johns Hopkins Bloomberg School of Public Health. One of the main concerns about the outbreak in India and its implications for other countries is the B.1.617 coronavirus variant, Peters said in a Thursday briefing. Peters said the new mutant makes up 80% of all COVID-19 cases in India but is also significant in the United Kingdom and Italy.“It’s also arrived in the U.S., although it is currently in low proportions,” Peters said. “The problem is that it seems to be much more transmissible than the earlier virus, and we’re yet to see whether it is also causing more serious illness, or makes it less susceptible to the vaccine.”
UPI, May 20, 2021
This is because new waves of infections in India, as well as in Asia, South America, and Africa, could prolong the pandemic by fueling the spread of new variants of the coronavirus through travel and human migration, according to Dr. Anita Shet, of the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health in Baltimore… “The current wave of COVID-19 in India is clearly a humanitarian crisis there,” her colleague, Dr. David Peters, added on the call.
PlOS Blogs, May 17, 2021
Dr. Anita Shet: Providing oxygen therapy at the patients’ doorsteps can reduce inequities in healthcare access. When the entire family is suffering from COVID-19, the caregiving responsibilities of women members get multiplied, even if they themselves are sick. Further, women often end up prioritizing the healthcare needs of other family members over their own. Given the rapid progression of desaturation and decompensation in some individuals, this gender-specific delay can be fatal for many.
Al Jazeera, May 17, 2021
Brian Wahl, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health’s Department of International Health in New Delhi, says that the health infrastructure in rural parts of India is not equipped for such a surge in cases.“We know that in rural parts, access to quality services is challenging and these areas highly depend on frontline health workers only. We know that a mass gathering has the potential to be a super spreader event ..,” he said.
Patrika Group, May 17, 2021
Interview with Dr. Amita Gupta
USA Today, May 12, 2021
In the past decade, doctors have seen only a handful of cases in India. But in the past month, they’re reporting tens of thousands of cases, said Dr. Bhakti Hansoti, associate professor in the department of emergency medicine and international health at the Johns Hopkins Bloomberg School of Public Health.“We’ve seen this skyrocket in recent weeks,” she said. “It consumes a lot of resources especially during this pandemic right now in India where health care resources are stretched at the limit.”
TIME, May 12, 2021
The B.1.617 variant of the virus, first detected in India, has now been found in 44 countries on every continent except Antarctica—including Nepal, the U.S. and much of Europe. Scientists say it could be more infectious and better at avoiding humans’ immune systems. On May 10, the World Health Organization declared it a variant of “global concern.” And because only around 0.1% of positive samples in India are being genetically sequenced, “there may well be others that have emerged,” says Amita Gupta, deputy director of the Johns Hopkins University Center for Clinical Global Health Education.
East Asia Forum, May 11, 2021
Pravin Krishna, Chung Ju Yung Distinguished Professor of International Economics and Business at Johns Hopkins University, is mentioned.
Financial Express (India), May 11, 2021
In an exclusive interview, Dr Amita Gupta, professor of Infectious Diseases at the John Hopkins School of Medicine and the co-director of the recently launched John Hopkins India Institute talks of the role that targeted lockdowns can play and what India could look at to be better prepared for the third wave.
Thompson Reuters Foundation News, May 07, 2021
Dr. Anita Shet: The United States has now fully vaccinated almost one third of its people, and is viewing the horizon ahead with hope. But one wonders if the horrors of 2020 can truly be left behind when far away in India, the new coronavirus surge has wrought unprecedented anguish and chaos.
WPLG Local 10 News, Miami/Fort Lauderdale, April 07, 2021
Dr. Amita Gupta is interviewed
WJZ, CBS, Baltimore, May 06, 2021
“Within India, there are many, many families – millions of families suffering tremendously – so we’re thinking of the short-term and long-term need. Everything from food support to mental health support and where to go to get these things,” said Dr. Amita Gupta, a professor of medicine and international health at the Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health.
Phoenix TV (Hong Kong), May 04, 2021
Broadcast in Mandarin; Dr. Amita Gupta’s interview is in English
The Hill, May 04, 2021
Drs. Amita Gupta, David Peters, Brian Wahl: There is a wretched inequality playing out in the world. As the U.S. and other high-income countries have dramatically reduced the burden of COVID-19, the daily number of confirmed cases and deaths globally is now greater than ever before. This increase is being driven by an alarming wave of cases currently ravaging India. While official sources cite more than 360,000 cases and 3,000 deaths per day, many experts believe these numbers could be substantially underestimated.
Los Angeles Times, May 03, 2021
“What happens in India matters to the entire world,” Dr. Amita Gupta, chair of the Johns Hopkins India Institute, said in a Facebook conversation Thursday. “We care from a humanitarian perspective, a public health perspective and a health-security perspective.”
Vox, April 29, 2021
“Providing any surplus rapid-antigen tests that could allow people with Covid to test at home would help to alleviate stress on the testing infrastructure here,” Brian Wahl, an India-based epidemiologist with the Johns Hopkins Bloomberg School of Public Health, said.
Public Health on Call: Johns Hopkins Podcast Series, April 29, 2021
Evidence and experts to help you understand today’s public health news—and what it means for tomorrow.
Scroll.in, April 29, 2021
The most urgent reason for this recommendation is to stop further deterioration of India’s healthcare infrastructure.
USA Today, April 28, 2021
Even though she’s in Baltimore, far from the tragedies unfolding in India, Gupta said she and many others are directly touched by them. “This effects the whole world,” she said. “This is not just some faraway place.”
Johns Hopkins Hub, April 28, 2021
The university is working urgently with partners on the ground to offer support and expertise to India, with efforts organized and led by the newly created Johns Hopkins India Institute.
Johns Hopkins Hub, April 28, 2021
The Johns Hopkins India Institute leverages 90 years of groundbreaking work in the South Asian country to tackle health, education, and economic challenges worldwide.
IndiaSpend Hindi, April 17, 2021
Cases of coronavirus increase by 400% in Haridwar during Kumbh Mela. (In Hindi)